Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Cardiomyopathies sequencing

PROVIDER: PRJNA1090063 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28397700.fastq.gz	Fastqsanger.gz
	SRR28397701.fastq.gz	Fastqsanger.gz
	SRR28397702.fastq.gz	Fastqsanger.gz
	SRR28397703.fastq.gz	Fastqsanger.gz
	SRR28397704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 72

Similar Datasets

Truncating variant in MYOF gene is associated with limb-girdle type muscular dystrophy and cardiomyopathy

Project description:Even though genetic studies of individuals with neuromuscular diseases have uncovered the molecular background of many cardiac disorders such as cardiomyopathies and inherited arrhythmic syndromes, the genetic cause of a proportion of cardiomyopathies associated with neuromuscular phenotype still remains unknown. Here, we present a clinical case with a combination of cardiomyopathy and limb-girdle type muscular dystrophy where whole exome sequencing identified myoferlin (MYOF) - a member of the Ferlin protein family and close homolog of DYSF - as the most likely candidate gene. The disease-causative role of the identified variant c.[2576delG; 2575G>C], p.G859fs is supported by functional studies in vitro using primary patient's satellite cells, including both RNA sequencing and morphological studies, as well as recapitulating of muscle phenotype in vivo in zebrafish experiments. We provide the first evidence supporting a role of MYOF in human muscle disease.

2019-08-24 | GSE119027 | GEO

Mus musculus

Project description:Gene expression profiling on mouse models of cardiomyopathies

| PRJNA118353 | ENA

AAV-mediated transduction of the nuclear-coded mitochondrial Ant1 gene ameliorates cardiomyopathy in Ant1-/- mouse: A step toward treating mitochondrial disease.

Project description:Primary mitochondrial disease (PMD) patients manifesting cardiomyopathy are twice as likely to die as other PMD patients. One PMD with cardiomyopathy is caused by null mutations in the heart-muscle isoform of the adenine nucleotide translocator (ANT1) gene, the severity of the cardiomyopathy being mediated by the mitochondrial DNA (mtDNA). To perfect strategies for addressing mitochondria cardiomyopathy, we generated an Ant1 null mouse and combined it with our ND6P25L mtDNA mutation to mimic the hypertrophic versus dilated cardiomyopathies observed in patients, respectively. We then transduced the neonatal Ant1-/- and Ant1-/-+ND6P25L mouse hearts with an AAV9-pDesmin-GFP-Ant1 cDNA vector. Restoration of just 10% Ant1 gene expression was sufficient to ameliorate the cardiomyopathies in these mice. Proteomics and single nucleus RNA sequencing (snRNA-seq) revealed the reversal of dysregulated mitochondrial metabolic genes including PGC1α as well as cardiac contractile and extracellular matrix proteins. Hence, modest increase in cardiac mitochondrial energetics can have profound benefits on cardiac function and is effective in treating mitochondrial cardiomyopathy.

2025-06-01 | GSE280991 | GEO

Deficiency in glucose transporter 12 results in heart failure and a diabetic phenotype in zebrafish

Project description:Cardiomyopathies-associated metabolic pathologies (e.g. T2D and insulin resistance) are a leading cause of mortality. It is known that the association between the pathologies works in both directions, where heart failure can lead to metabolic derangements such as insulin resistance. This intricate crosstalk exemplifies the importance of a fine coordination between one of the most energy demanding organs and an equilibrated carbohydrate metabolism. In this light, to assist in the understanding of the role of insulin regulated glucose transporters and the development of cardiomyopathies, we set out to study GLUT12. GLUT12 is a novel insulin regulated GLUT expressed in the main insulin sensitive tissues such as cardiac and skeletal muscle and adipose tissue. This study investigates the role of GLUT12 in heart failure and diabetes by developing a model for glut12 deficiency in zebrafish. 6 samples in total were analyzed. 3 replicates from control samples (injected with contol MO) and 3 replicates from glut12 morphant samples (injected with glut12 splice MO). In each sample 10 embryos were pooled.

2014-12-04 | E-GEOD-59683 | biostudies-arrayexpress

NHLBI TOPMed: The Genetic Causes of Unexplained Cardiomyopathies (UNID_CM)

Project description:NHLBI TOPMed: The Genetic Causes of Unexplained Cardiomyopathies (UNID_CM)

| PRJNA715518 | ENA

NHLBI TOPMed: The Genetic Causes of Unexplained Cardiomyopathies (UNID_CM)

Project description:NHLBI TOPMed: The Genetic Causes of Unexplained Cardiomyopathies (UNID_CM)

| PRJNA715519 | ENA

NHLBI TOPMed: Molecular Mechanisms of Inherited Cardiomyopathies and Arrhythmias

Project description:NHLBI TOPMed: Molecular Mechanisms of Inherited Cardiomyopathies and Arrhythmias

| PRJNA398975 | ENA

Homo sapiens

Project description:NHLBI TOPMed: Molecular Mechanisms of Inherited Cardiomyopathies and Arrhythmias

| PRJNA398976 | ENA

Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy [Exome-Seq]

Project description:Phospholamban R14del mutazion (PLN-R14del) has been identified in a large family pedigree in which heterozygous carriers exhibited inherited dilated cardiomyopathy (DCM) and death by middle age. To better understand the causal link between the mutations in PLN and DCM pathology, we derived induced pluripotent stem cells from a DCM patient carrying the PLN R14del mutation. We showed that iPSC-derived cardiomyocytes recapitulated the DCM-specific phenotype and demonstrated that either TALEN-mediated genetic correction or combinatorial gene therapy resulted in phenotypic rescue. Our findings offer novel insights into the pathogenesis caused by mutant PLN and point to the development of potential new therapeutics of pathogenic genetic variants associated with inherited cardiomyopathies. Submitter confirms there are no patient privacy concerns with these data. iPSCs were derived from a female patient carrying a heterozygous mutation (R14del) in the PLN gene. Tree samples were analyzed: R14del-CMs (clone L2), corrected R14del-CMs (clone L2GC1) and corrected R14del-CMs (clone L2GC2)

2015-02-09 | E-GEOD-65762 | biostudies-arrayexpress

Deficiency in glucose transporter 12 results in heart failure and a diabetic phenotype in zebrafish

2014-12-04 | GSE59683 | GEO